Zydus Pharmaceuticals (USA) Inc: Nelarabine Injection, 250mg/50mL, (5mg/mL)
Recall reason: Failed Impurities/Degradation Specifications. Recalled by Zydus Pharmaceuticals (USA) Inc. Distribution: USA Nationwide. Classification (Class II — potential health risk). Affected lots/NDC/dates: Lot: a) P300197, Exp. Aug-2025; P400113, Exp. May-26; b) P300169, Exp. Jun-2025; P400115, Exp. May-2026.. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report